Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028
Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners,…
Sun Pharma ropes in Richard Ascroft as North America CEO
Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…
Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen
Shares of Torrent Pharmaceuticals rose as much as 4 percent to Rs 3,350 on Friday after global brokerage JPMorgan upgraded the stock to ‘Overweight’, citing strong growth levers in the…
Chemotherapy drugs made by Indian firms fail quality tests, shows study
Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, the Bureau of…
Hundreds of weight loss and diabetes jab users report pancreas problems
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to launch a study into side-effects. Some cases of pancreatitis…
Act on Cataract now with Next Generation Technology to keep Blindness at bay
‘See Blindness Risk off’ with ‘Centre for Sight’ Hospitals in Cataract Awareness Month New Delhi: Cataract in India is leading to blindness which can well be prevented by timely diagnosis.…
‘Stop selling, stocking, or using’: List of drugs and cosmetic banned by Karnataka
The Karnataka government has banned a total of 15 drugs and cosmetic products after they were found to be “Not of Standard Quality” by the state’s Drugs Testing Laboratory. Health…
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg
Hyderabad: Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…
Glenmark Pharma launches TEVIMBRA in India
Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…